Clinical Trials Logo

Lactate clinical trials

View clinical trials related to Lactate.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05582824 Recruiting - Metabolism Clinical Trials

Lactate Metabolism in the Hypoperfused Critically Ill

Start date: September 15, 2022
Phase:
Study type: Observational

Investigating lactate metabolism in critically ill patients whom are hypoperfused by preforming metabolomics via liquid chromatography-mass spectrometry.

NCT ID: NCT05052619 Recruiting - Antibiotics Clinical Trials

Preventive Therapy of Postoperative Intra-abdominal Infection Based on Serum Lactate Changes

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

Intra-abdominal infection is one of the most serious complications after pancreatic resection. The preventive use of antibiotics intraoperatively could reduce the incidence rate of postoperative intra-abdominal infection. According to the previous retrospective study, changes of serum lactate level on postoperative day1 could predict the incidence rate of postoperative intra-abdominal infection. This prospective RCT is to further validate and promote the findings and conclusion.

NCT ID: NCT04238611 Recruiting - Exercise Clinical Trials

Minimally-Invasive Realtime Assessment of Continuous Lactate in Exercise

MIRACLE
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Lactate is a compound produced as a by-product of glycolysis. The increase in lactate concentration can result from a variety of causes, such as during anaerobic metabolism in exercise or haemodynamic shock in conditions such as sepsis. The study will aim to validate a novel microneedle-based minimally invasive device for the continuous measurement of lactate during exercise.

NCT ID: NCT03163719 Recruiting - Lactate Clinical Trials

Impact of Early Lactate Dosage Compared to CK for Diagnosis of a Suspected Seizure

Start date: November 28, 2016
Phase: N/A
Study type: Observational

Defining the origin of a seizure remains a difficult diagnosis. The presence of witness is not systematic, the clinical examination can be little contributory, and the delay recommended by the FSN is often surpassed for the realization of Creatine kinase (4h). In the event of a suspected seizure, an initial blood test with Creatine kinase and Lactates is often done on admission of the patient in other words before the 4hours delay. It seems interesting to harmonize the practices, to limit the patient wait in the emergencies for a deferred dosage of CK at 4 hours from the seizure and to identify an early biological marker. Objectives: To evaluate the value of blood CK and Lactate dosage in emergency procedures in the diagnosis of generalized seizures.